Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849)
Clinical trial NCT02564211 · COMPLETED
Trial details
- NCT number
- NCT02564211
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-26
- Primary completion
- 2017-03-07
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.